You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: 8,178,554


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,178,554
Title:Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
Abstract: The invention relates to new heterocyclic compounds of general formula (I), and their salts with a base or an acid: ##STR00001## The invention also relates to a process for the preparation of these compounds as well as their use as medicaments, in particular as anti-bacterial agents.
Inventor(s): Lampilas; Maxime (Romainville, FR), Aszodi; Jozsef (Tucson, AZ), Rowlands; David Alan (Poissy, FR), Fromentin; Claude (Paris, FR)
Assignee:
Application Number:13/068,399
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,178,554

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent holders, and legal professionals. This article will delve into the details of United States Patent 8,178,554, exploring its claims, the patent landscape, and relevant legal and technical considerations.

Patent Overview

United States Patent 8,178,554, hereafter referred to as the '554 patent, is a specific example of a patent that has undergone various legal and technical analyses. While the exact details of this patent are not provided in the sources, we can use general principles and similar cases to understand its scope and claims.

Claims Analysis

Independent and Dependent Claims

Patent claims are the heart of any patent, defining the scope of the invention. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details[5].

  • Independent Claims: These claims are critical as they define the broadest scope of the invention. For example, in the case of the '742 patent mentioned in the Cellect LLC case, independent claims such as claim 1 would outline the core invention without referencing other claims[1].

  • Dependent Claims: These claims narrow down the invention by adding specific limitations or features to the independent claims. They are often used to protect various aspects of the invention and to provide a fallback position in case the independent claims are challenged.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is a critical step in patent litigation and is governed by the principles outlined in the Federal Circuit's decisions. The claims must be construed to determine their scope and whether they read on prior art or other patents[1].

Patent Landscape

Continuations and Continuations-in-Part

The patent landscape can be complex, especially when dealing with continuations and continuations-in-part. These types of patents are filed based on earlier applications and can extend the life of the original patent.

  • Continuations: These are new patent applications that are filed while an earlier application is still pending. They allow the inventor to pursue additional claims based on the same disclosure as the earlier application.

  • Continuations-in-Part: These combine subject matter from an earlier application with new subject matter. For instance, the '369 and '626 patents in the Cellect LLC case were continuations-in-part of the '255 patent, indicating a complex family of patents with overlapping subject matter[1].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent. This is particularly relevant when dealing with continuations and continuations-in-part, as seen in the Cellect LLC case where ODP analysis was crucial in determining the validity of the patents[1].

Legal Considerations

Patent Term Adjustment (PTA)

PTA is a mechanism that adjusts the term of a patent to account for delays during the prosecution process. However, as the Cellect LLC case highlights, PTA does not extend the term of a patent past the date of a terminal disclaimer. This means that even if a patent receives PTA, it cannot exceed the expiration date set by a terminal disclaimer[1].

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections. By disclaiming the term of a later patent that would extend beyond the term of an earlier patent, inventors can avoid ODP issues. The Cellect LLC case emphasizes that terminal disclaimers and ODP analyses should be considered after any PTA has been granted[1].

Technical Considerations

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents granted between 1976 and 2014. This dataset can be used to analyze trends and patterns in patent claims, including the scope and complexity of claims in various technical fields[3].

Impact on Business and Innovation

Small Claims Patent Court

The concept of a small claims patent court, as studied by ACUS, aims to provide a more accessible and cost-effective way for small inventors and businesses to resolve patent disputes. This could significantly impact the patent landscape by making it easier for smaller entities to enforce their patents and defend against infringement claims[2].

Case Studies and Analogies

Cellect LLC Case

The Cellect LLC case provides a detailed example of how ODP and PTA can affect the validity and term of patents. This case highlights the importance of careful claim drafting and the need to consider the entire patent family when assessing patentability and term adjustments[1].

Key Statistics and Trends

Patenting Activity

Data from the National Science Foundation (NSF) shows trends in patenting activity across different technical fields and geographic locations. This data can help in understanding the broader patent landscape and how patents like the '554 patent fit into it[4].

Expert Insights

Legal and Academic Perspectives

Experts in the field, such as those involved in the ACUS study on small claims patent courts, emphasize the need for clear and consistent legal frameworks. For instance, Andrei Iancu, former Undersecretary of Commerce for IP and Director of the USPTO, has highlighted the importance of balancing patent protection with the need for innovation and competition[2].

Practical Applications

Patent Strategy

Understanding the scope and claims of a patent is essential for developing a robust patent strategy. This includes deciding whether to file continuations or continuations-in-part, how to navigate ODP issues, and how to leverage PTA and terminal disclaimers to maximize patent term.

Challenges and Opportunities

Litigation and Enforcement

Patent litigation can be complex and costly. The '554 patent, like any other, must be carefully managed to avoid litigation and ensure enforcement. This includes monitoring for infringement, defending against challenges, and potentially using mechanisms like terminal disclaimers to overcome ODP issues.

Conclusion

Understanding the scope and claims of a patent like the '554 patent involves a deep dive into legal, technical, and strategic considerations. Here are some key takeaways:

  • Claims Analysis: Independent and dependent claims define the invention's scope.
  • Patent Landscape: Continuations and continuations-in-part can extend patent life but must navigate ODP.
  • Legal Considerations: PTA and terminal disclaimers are crucial in managing patent term.
  • Technical Considerations: Datasets like the USPTO's Patent Claims Research Dataset can provide insights into claim trends.
  • Impact on Business: Accessible dispute resolution mechanisms like small claims patent courts can benefit small inventors.
  • Expert Insights: Balancing protection and innovation is key, as emphasized by legal and academic experts.

Key Takeaways

  • Claims Construction: Accurate claim construction is vital for determining patent scope.
  • ODP Analysis: Prevents securing a second, later-expiring patent for the same invention.
  • PTA and Terminal Disclaimers: Manage patent term effectively to avoid ODP issues.
  • Patent Strategy: Careful planning is necessary to maximize patent term and avoid litigation.
  • Innovation and Competition: Balancing these elements is crucial for a healthy patent ecosystem.

FAQs

Q: What is the difference between independent and dependent claims in a patent? A: Independent claims define the invention broadly, while dependent claims narrow down the invention by adding specific limitations or features to the independent claims.

Q: How does Obviousness-Type Double Patenting (ODP) affect patent validity? A: ODP prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent.

Q: What is the purpose of Patent Term Adjustment (PTA)? A: PTA adjusts the term of a patent to account for delays during the prosecution process, but it does not extend the term past the date of a terminal disclaimer.

Q: Why is a small claims patent court being considered? A: To provide a more accessible and cost-effective way for small inventors and businesses to resolve patent disputes.

Q: How can the USPTO's Patent Claims Research Dataset be useful? A: It provides detailed information on claims from US patents, helping to analyze trends and patterns in patent claims.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States[2]
  3. Patent Claims Research Dataset - United States Patent and Trademark Office[3]
  4. Invention, Knowledge Transfer, and Innovation - National Science Foundation[4]
  5. 35 USC 282: Presumption of validity; defenses - United States Code[5]

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,178,554

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 8,178,554

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France00 10121Aug 1, 2000

International Family Members for US Patent 8,178,554

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
African Regional IP Organization (ARIPO) 1614 ⤷  Try for Free
Argentina 031716 ⤷  Try for Free
Australia 2001279905 ⤷  Try for Free
Australia 7990501 ⤷  Try for Free
Austria 263768 ⤷  Try for Free
European Patent Office 1307457 ⤷  Try for Free C 2016 055 Romania ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.